Hereditary angioedema: A therapeutic revolution.;L'angiœdème héréditaire: Une révolution thérapeutique

Revue de Medecine Interne

Volumn 33, Issue 3, 2012, Pages 150-154

  Bouillet, L ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Abdominal pain; Bradykinin; C1 inhibitor; Hereditary angioedema; Laryngeal edema

Indexed keywords

BRADYKININ;

ABDOMINAL PAIN; ANGIONEUROTIC EDEMA; EDEMA; GENETIC DISORDER; HUMAN; LARYNX EDEMA; PRACTICE GUIDELINE; QUALITY OF LIFE; SHORT SURVEY; SOCIAL LIFE;

ANGIOEDEMAS, HEREDITARY; DIFFUSION OF INNOVATION; HUMANS; INTERNAL MEDICINE; MODELS, BIOLOGICAL; PREVENTIVE MEDICINE; RARE DISEASES; THERAPIES, INVESTIGATIONAL;

EID: 84857441561     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.12.005     Document Type: Short Survey

References (28)

1. Bouillet L., Boccon-Gibod I., Massot C. Les angiœdèmes bradykiniques héréditaires ou acquis. Rev Med Interne 2011, 32:225-231.
2. Agostoni A., Aygoren-Pursun E., Binkley K.E., Blanch A., Bork K., Bouillet L., et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 2004, 114(suppl. 3):S51-S131.
3. Zuraw B.L., Clinical practice. Hereditary angioedema. N Engl J Med 2008, 359:1027-1036.
4. Bork K., Staubach P., Eckardt A.J., Hardt J. Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol 2006, 101:619-627.
5. HAEi. International patient organization for C1 Inhibitor deficiencies. State of management of HAE in Europe. [Accessed June 30, 2011]. http://www.haei.org/sites/default/files/public/201101_HAEi_Report.pdf.
6. Bork K., Barnstedt S.E., Koch P., Traupe H. Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 2000, 356:213-217.
7. Moore G.P., Hurley W.T., Pace S.A. Hereditary angioedema. Ann Emerg Med 1988, 17:1082-1086.
8. Agostoni A., Cicardi M. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Medicine (Baltimore) 1992, 71:206-215.
9. Davis A.E. The pathophysiology of hereditary angioedema. Clin Immunol 2005, 114:3-9.
10. Nzeako U.C., Frigas E., Tremaine W.J. Hereditary angioedema: a broad review for clinicians. Arch Intern Med 2001, 161:2417-2429.
11. Vitrat-Hincky V., Gompel A., Dumestre-Perard C., Boccon-Gibod I., Drouet C., Cesbron J.Y., et al. Type III hereditary angio-oedema: clinical and biological features in a French cohort. Allergy 2010, 65:1331-1336.
12. Zuraw B.L. Hereditary angioedema: a current state-of-the-art review IV: short- and long-term treatment of hereditary angioedema: out with the old and in with the new?. Ann Allergy Asthma Immunol 2008, 100(suppl. 2):S13-S18.
13. Frank M.M., Gelfand J.A., Atkinson J.P. Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 1976, 84:580-593.
14. Lumry W.R., Castaldo A.J., Vernon M.K., Blaustein M.B., Wilson D.A., Horn P.T. The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression. Allergy Asthma Proc 2010, 31:407-414.
15. Gompels M.M., Lock R.J., Abinun M., Bethune C.A., Davies G., Grattan C., et al. C1 inhibitor deficiency: consensus document. Clin Exp Immunol 2005, 139:379-394.
16. Frank M.M. Hereditary angioedema: the clinical syndrome and its management in the United States. Immunol Allergy Clin North Am 2006, 26:653-668.
17. Bowen T. Hereditary angioedema: beyond international consensus-circa December 2010-The Canadian Society of illergy and ilinical immunology, Dr David Mc Courtie Lecture. Allergy Asthma Clin Immunol 2011, 7:1-14.
18. Bowen T., Cicardi M., Farkas H., Bork K., Longhurst H.J., Zuraw B, et al. 2010 international consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010, 6:24-36.
19. Craig T.J., Levy R.J., Wasserman R.L., Bewtra A.K., Hurewitz D., Obtułowicz K., et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 2009, 124:801-808.
20. Cinryze Summary of Product Characteristics. Available at [Accessed June20, 2011]. http://www.medicines.org.uk/.
21. Zuraw B., Cicardi M., Levy R.J., Nuijens J.H., Relan A., Visscher S., et al. Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 2010, 126:821-827.
22. Cicardi M., Aberer W., Arcoleo F., Bas M., Bjorkander J., Bouillet L., et al. Icatibant, a novel bradykinin B2 receptor antagonist, is effective in the treatment of acute attacks in patients with hereditary angioedema. N Engl J Med 2010, 363:532-541.
23. Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Reshef A, et al. Results from FAST-3: a phase III randomized, double-blind, placebo-controlled, multicenter study of subcutaneous icatibant in patients with acute hereditary angioedema (HAE) attacks. Program and abstracts of AAAAI 2011 ; March 18-22, 2011; San Francisco, California. Abstract L2.
24. Sheffer A.L., Campion M., Levy R.J., Li H.H., Horn P.T., Pullman W.E. Ecallantide (DX-88) for acute hereditary angioedema attacks: Integrated analysis of 2 double-blind, phase 3 studies. J Allergy Clin Immunol 2011, 128:153-159.
25. Bork K., Hardt J., Staubach-Renz P., Witzke G. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 112:58-64.
26. Zuraw B.L., Busse P.J., White M., Jacobs J., Lumry W., Baker J., et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Eng J Med 2010, 363:513-522.
27. Kreuz W., Martinez-Saguer I., AygorenPursun E., Rusicke E., Heller C., Klingebiel T. C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion 2009, 49:1987-1995.
28. Craig T., Riedl M., Dykewicz M.S., Gower R.G., Baker J., Edelman F.J., et al. When is prophylaxis for hereditary angioedema necessary?. Ann Allergy Asthma Immunol 2009, 102:366-372.